Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery—a clinical study

References

• Antonsen S., Brandslund I., Clemesen S., Soefeldt S., Madsen T., Alstrup P. Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass. Scand J Thor Cardiovasc Surg 1987; 21: 47–52
   PubMed Web of Science ®Google Scholar
• Arnander C., Dryjski M., Larsson R., Olsson P., Swedenborg J. Thrombin uptake and inhibition on endothelium and surface with a stable heparin coating. A comparative in vitro study. J Biomed Mat Res 1986; 20: 235–246
   PubMed Web of Science ®Google Scholar
• Bagge L., Lilienberg G., Nyström S. O., Tyden H. Coagulation, fibrinolysis and bleeding after open-heart surgery. Scand J Thor Cardiovasc Surg 1986; 20: 151–160
   PubMed Web of Science ®Google Scholar
• Bindslev L., Eklund J., Norlander O., Swedenborg J., Olsson P., Nilsson E., Larm O., Gouda I., Malmberg A., Scholander E. Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anesthesiology 1987; 67: 117–120
   PubMedGoogle Scholar
• Cavarocchi N. C., Schaff H. V., Orszulak T. A., Homburger H. A., Schnell W. A., Pluth J. R. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery 1985; 98: 525–530
   PubMed Web of Science ®Google Scholar
• Hattersley P. G. Activated coagulation time of whole blood. JAMA 1966; 196: 436–440
   PubMed Web of Science ®Google Scholar
• Hellem A. J. Platelet adhesiveness in von Willebrand disease: A study with a new modification of the glassbeads method. Scand J Med 1970; 7: 374–382
   Google Scholar
• Högman C. F., Bagge L., Thorén L. The use of blood components in surgical transfusion therapy. World J Surg 1987; 11: 2–13
   PubMedGoogle Scholar
• Kirklin J. K., Westaby S., Blackstone E. H., Kirklin J. W., Chenoweth D. E., Pacifico A. D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–857
   PubMed Web of Science ®Google Scholar
• Kodama K., Pasche B., Olsson P., Adolfsson L., Larm O., Riesenfeld J. Antithrombin III binding to surface immobilized heparin and its relation to F Xa inhibition. Thromb Haemostas 1987; 58: 1064–1067
   PubMed Web of Science ®Google Scholar
• Larm O., Larsson R., Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Devices Artif Organs 1983; 2: 161–173
   Google Scholar
• Nilsson L., Brunnkvist S., Nilsson U., Nyström S. O., Tyden H., Venge P., Åberg T. Activation of inflammatory systems during cardiopulmonary bypass. Scand J Thor Cardiovasc Surg 1988; 22: 51–53
   PubMed Web of Science ®Google Scholar
• Nilsson L., Storm K. E., Thelin S., Bagge L., Hultman J., Thorelius J., Nilsson U. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif Organs 1990; 14: 46–48
   PubMedGoogle Scholar
• Nilsson L., Bagge L., Nyström S. O. Blood cell trauma and postoperative bleeding; comparison of bubble and membrane oxygenators and observations on coronary suction. Scand J Thor Cardiovasc Surg 1990; 24: 65–69
   PubMed Web of Science ®Google Scholar
• van Oeveren W., Kazatchkine M. D., Descamps-Latscha B., Maillet F., Fischer E., Carpentier A., Wildevuur C. R.H. Deleterious effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 89: 888–899
   PubMed Web of Science ®Google Scholar
• Pasche B., Kodama K., Larm O., Olsson P., Swedenborg J. Thrombin inactivation on surface with covalently bonded heparin. Thromb Res 1986; 44: 739–748
   PubMed Web of Science ®Google Scholar
• Peters J., Radermacher P., Kuntz M. E., Rosenbauer K. A., Breulmann M., Burrig K. F., Hopf H. B., Rossaint R., Schulte H. D., Olsson P., Falke K. J. Extracorporeal CO2-removal with a heparin coated artificial lung. Intensive Care Med 1988; 14: 578–584
   PubMedGoogle Scholar
• Thelin S., Bagge L., Hultman J., Borowiec J., Nilsson L., Thorelius J. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. Eur J Cardiothorac Surg 1991; 5: 486–491
   PubMedGoogle Scholar
• Videm V., Nilsson L., Venge P., Si Svennevig J. L. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 1991; 15: 90–95
   PubMed Web of Science ®Google Scholar